There are several new opportunities for funding available with applications due in the fourth quarter of 2024 including those from NIH, NINDs and NIDA.
The PHS 2024-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. There are four Omnibus Solicitations:
PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).
PA-24-247: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed).
PA-24-248: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required).
Please note: Section V. Application Review information has been updated, including:
The first application due date is Thursday, September 5, 2024.
NINDS Diversity Workforce Training (R25) NINDS is offering up to $250,000 per year for programs aimed at enhancing diversity within the translational neuroscience research workforce. This funding supports mentoring, research experiences, and skills development for post-baccalaureate, graduate, post-doctoral, and junior faculty participants.
Application Deadline: September 26, 2024
2. NIDA Research Funding for Non-Disordered Drug Use NIDA is seeking proposals for R&D activities that create products to address health consequences of non-disordered drug use. This opportunity includes FDA-regulated areas such as pharmacotherapeutics and diagnostic devices.
Application Deadline: December 2, 2024
